These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6430492)

  • 1. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complement system in disseminated lupus erythematosus].
    Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-dsDNA and complement profiles in systemic lupus erythematosus.
    Swaak AJ; Groenwold J; Bronsveld W; Douma J; Feltkamp TE
    Neth J Med; 1981; 24(4):152-6. PubMed ID: 7024831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 6. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoconglutinins and complement in systemic lupus erythematosus.
    Casali P; Scevola M
    Experientia; 1976 Dec; 32(12):1596-7. PubMed ID: 1021462
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of combined immunosuppressive treatment with Imuran and prednisone on the concentration of selected immune proteins in the serum of patients with lupus erythematosus].
    Chwal Z
    Pol Tyg Lek; 1976 May; 31(16):659-61. PubMed ID: 1083976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of serum concentration of C3 and C4 for the diagnosis, prognosis and treatment of SLE].
    Yasue T; Akutsu J; Shinjô H; Sasada K
    Nihon Hifuka Gakkai Zasshi; 1975 Dec; 85(14):875-83. PubMed ID: 1240511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic and prognostic significance of complement fixing anti-n-DNA antibodies in systemic lupus erythematosus].
    Pozzoli R
    Quad Sclavo Diagn; 1987 Mar; 23(1):65-71. PubMed ID: 3441594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum-complement factors in the pseudo-LE syndrome (author's transl)].
    Kaboth U; Niederhut H; Brunner G
    Dtsch Med Wochenschr; 1977 Apr; 102(13):470-3. PubMed ID: 844426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between immune complexes, anti-DNA antibodies and complement in lupus nephropathy].
    Pastore A; Manno C; Losuriello V; Vox E; Schena FP
    Minerva Nefrol; 1981; 28(4):503-8. PubMed ID: 7339520
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of three assays for anti-DNA with three assays for the measurement of the role of complement in systemic lupus erythematosus in adolescents.
    Miller JJ; Hsu YP; Osborne CL; Kredich DW
    J Rheumatol; 1980; 7(5):660-4. PubMed ID: 7003143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A longitudinal clinical study and laboratory survey of systemic lupus erythematosus].
    Golan DT; Gilhar A; Pick IS; Weiss C; Bentwitch Z
    Harefuah; 1980 Mar; 98(6):241-4. PubMed ID: 7409641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.